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ABSTRACT
Author: Golz, Brian T. Master of Science in Biomedical Engineering
Institution: Purdue University
Degree Received: December 2017
Title: Development of a 3D Collagen-Hydroxyapatite Composite in vitro Culture Model for
Osteoblasts and Osteocytes
Major Professor: Russell Main

Osteoporosis is a disease characterized by a severe loss in bone mineral density, putting
individuals at elevated risk of bone fracture. The disorder is extremely prevalent, with high
associated costs. Pharmaceutical treatments exist, but currently have severe drawbacks,
and preventative measures are eﬀective primarily within an individual's ﬁrst two decades
of life, long before the normal age of diagnosis. To better develop treatments in a highthroughput physiological setting, an in vitro model for bone cell culture that accurately
recapitulates the in vivo cellular environment is needed. Thus, a 3D culture system has been
developed utilizing porcine skin collagen oligomers (PSC) and precipitated hydroxyapatite
(HA) nanoparticles to support de novo bone formation and diﬀerentiation of osteoblasts
into osteocytes. Cells isolated from DMP1-Cre x mT/mG mice were cultured in 3D matrices
with diﬀering concentrations of PSC and HA for 3 and 56 days in osteogenic medium, before
being sampled for testing. Fixed culture sections were imaged using confocal microscopy
to quantify diﬀerentiation of osteoblasts to osteocytes, indicated by the shift from cellular
expression of red ﬂuorescent protein to green ﬂuorescent protein through the activation of
the promoter for the osteocyte-speciﬁc dentin matrix protein 1. These data demonstrated
a signiﬁcant proportional increase in late osteoblasts and and osteocytes. µCT analysis
showed a signiﬁcant increase in mineralization of the ECM, exclusive to cultures initially
formed with HA. This was reﬂected by increased mechanical stiﬀness at high strain in some
culture conditions.

1

1
1.1

INTRODUCTION

Pathology and Clinical Need
Bones are dynamic structures capable of continuously remodeling throughout life to

accommodate the physical demands placed on them while also removing unnecessary or
damaged bone tissue. This allows the skeleton to remain suﬃciently robust, yet lightweight.
In addition to providing structural support to the body, the skeleton houses the bone marrow
that produces blood cells and serves as a reservoir for calcium (Ca2+ ) and phosphates. The
primary cells found within bone include osteoblasts, osteoclasts, and osteocytes. Osteoblasts
are responsible for depositing new bone material, 17,99,101 while osteoclasts resorb bone if
damaged or needed for quick release of calcium into an individual's blood. Osteocytes
signal the osteoblasts and osteoclasts to increase or reduce their activities depending on
chemical or mechanical factors, 46,49 as well as being involved in bone mineral homeostasis via
endocrine signaling to other organs such as the kidneys. 54 When the bone-forming activities
of osteoblasts fail to keep pace with the bone-resorbing activities of osteoclasts, the skeleton
loses mineral density and grows weaker, eventually resulting in osteoporosis.
According to the World Health Organization, someone is deﬁned as osteoporotic if
their bone density is at least 2.5 standard deviations below that of a healthy young adult. 47
Osteoporosis is a signiﬁcant problem in developed countries, and is growing in prevalence in
developing countries with increasing lifespans and poorer nutrition. 47 An estimated 71% of
aﬀected individuals are women 16 , being particularly susceptible in post-menopausal years. 38
Annual costs associated with osteoporosis in the United states have been estimated to be at
least $13.7 billion, and up to roughly $20 billion. 16 As the world's population over 60 years
of age continues to grow, from just over 900 million in 2015 to a projected 1.4 billion by 2030
and 2.1 billion in 2050, 15 costs and disability associated with osteoporosis will drastically
increase. While more developed regions have lower projected elderly population growth, they
are expected to have signiﬁcant escalation in osteoporosis-related burden. In Germany, 2015
projections for 2050 had osteoporosis-attributable fractures per year increasing by 138%, and
overall osteoporosis-related costs increasing by 473%. 11
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The most beneﬁcial treatments for osteoporosis are preventative in nature, consisting of
load-bearing activities that promote bone formation, such as running and weightlifting, and
ensuring adequate intake of nutrients, such as calcium. However, after the ﬁrst two decades
of life, these measures are limited in their potential eﬀectiveness, 3,52,95 and load-bearing activities pose a risk for fracture following the onset of osteoporosis. Conventional treatments
for osteoporosis include the use of bisphosphonates (BPs) and denosumab, which inhibit the
activation of osteoclasts. 7,23,24 However, BP treatments have been widely associated with osteonecrosis of the jaw, 59,87 hypocalcemia 19,57,64,85 , and possibly increased risk for esophageal
cancer. 102 siRNA targeting Sclerostin (an inhibitor of bone formation) has been explored as
an option for treating osteoporosis by anabolic means, but has recently been found to pose
an increased risk for the development and metastasis of osteosarcoma cells. 107 Teriparatide
(ForteoTM ) is a subunit of parathyroid hormone (PTH), and has been shown to be eﬀective
in preventing fractures in osteoporotic patients, 69 but commonly results in headache, nausea,
dizziness, and limb pain, and cannot be taken by patients with osteosarcoma or kidney disease. 1 As all current osteoporosis treatments carry severe drawbacks, better approaches for
treating this disorder should be pursued, which in turn require an improved understanding
of how bone cells interact and respond to various stimuli in their native setting.

1.2

Bone Cell Physiology

Osteoblasts are cells of mesenchymal origin, 43 and are responsible for the formation of bone.
Procollagen is formed within the rough endoplasmic reticulum of osteoblasts, and then condensed into secretory granules, which are transported out of the cells via the Golgi apparatus. 17,62,99,101 Once in the extracellular matrix (ECM), procollagen metaloproteinases remove
terminal propeptides, allowing the procollagen molecules to self-assemble into ﬁbrils. 44 Hydroxyapatite is then deposited into this collagenous matrix speciﬁcally at sites where bone
sialoprotein (BSP) or dentin matrix protein 1 (DMP1) is bound to the type I collagen. 42
These crystals are then integrated into the ﬁbrils formed by these collagen molecules, as
shown in Figure 1.
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Figure 1: Nucleation of hydroxyapatite (HA) by BSP or DMP1 bound to collagen. i. A
negatively-charged region bonds with a calcium ion. ii. The calcium ion then binds phosphate ions. Successive
calcium and phosphate ions bind to the growing HA crystal.

Within bone, one of the particular characteristics of osteoblasts is their production of alkaline
phosphatase (ALP). 88 This protein is known to limit
the inhibitory eﬀect that pyrophosphates exercise on
HA crystal formation via binding to mineral, and
also supports the regulation of pyrophosphates via
the phosphorylation of osteopontin (OPN), another
osteoblast-speciﬁc protein. 2,33,67 Although such an inFigure 2: Bone cell network. Osteo-

teraction has not been directly addressed, it is likely cytes are embedded within the bone matrix
that ALP facilitates the nucleation of HA crystals by and secrete DMP1, mineralizing the matrix.
DMP1, produced by osteocytes.

81

Osteocytes (shown in Figure 2) diﬀerentiate

Osteoblasts occupy the bone surface and lay
down bone matrix, eventually transitioning
to an osteocytic phenotype or undergoing
apoptosis.

from osteoblasts, 37 and are estimated to comprise approximately 95% of bone cells. 34 During their diﬀerentiation from osteoblasts, they become embedded in the ECM that surrounds
them, 63 initializing the mineralization of that matrix area. Osteocytes are morphologically
characterized by dendritic processes formed following expression of E11. These processes reside in boney channels called canaliculi, and form gap junctions with other osteocytes in their
vicinity. 26,30,75,106 Following an osteoblast's diﬀerentiation into an osteocyte, it continues to
express BSP. 4 However, osteocytes are phenotypically distinct in their unique expression,
within bone, of DMP1. 45 Soluble DMP1 recruits osteoblasts from preosteoblasts, inducing
an increase in their expression of osteoblastic genes, although the mechanisms involved are
not clearly understood. 31 Downstream, DMP1 assists in forming hydroxyapatite crystals in
the collagenous ECM, binding the crystals to the collagenous matrix and regulating their
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growth. 36,41 The other major role attributed to osteocytes is to serve as the means of mechanotransduction within bone. While osteoblasts demonstrate a degree of mechanosensitivity
in 2D in vitro studies, osteocytes are understood to fulﬁll the vast majority of this role in
vivo. 46,49 However, there is a dearth of 3D in vitro investigation to elucidate the mechanotransductive functions of osteocytes and the cellular pathways involved.

1.3

State of the Field
Traditionally, bone cell cultures have used a 2D setting, such as petri dishes, tissue

culture ﬂasks, or well plates. The 2D settings for many studies on osteocytes and osteoblasts
do not accurately reﬂect the physiological, 3D environment these cells live in, and this
disparity is reﬂected in their phenotypes.
The presence of bone mineral in culture plays a role in promoting osteocyte gene expression. When cultured on a bulk 3D collagen matrix, osteocyte-like cells express sclerostin,
DMP1, and FGF23 at levels similar to those of cells grown in 2D culture. 40 Expression of
these osteocyte markers signiﬁcantly increased, however, when cells were cultured alongside
exogenous hydroxyapatite. The presence of hydroxyapatite also appears to promote the proliferation of primary osteoblasts, shown by osteoblasts cultured on collagen-hydroxyapatite
composite microbeads. 105 However, this microbead model did not induce osteoblasts to adopt
an osteocytic morphology and phenotype. Thus, while hydroxyapatite is a critical component
for an in vivo-like culture system, other parameters must also be considered.
If the physiological environment of osteoblasts and osteocytes is to be accurately recapitualted, it is important that the culture model allow for the formation of a network of
osteocytic cellular processes embedded within the matrix. A collagen-HA composite scaﬀold
was recently developed by lyophilizing aqueous mixtures of collagen and HA, and adhering
layers of this scaﬀolding together with collagen (Figure 3). 5 This construct supported cells,
but the seeding of cells into the construct was not entirely eﬃcient, limited to cells that
adhered after pipetting a suspension onto the construct. Moreover, the morphology of the
scaﬀold appears to be of a scale such that it resembles severely osteoporotic cancellous bone,
with trabecular thicknesses not greater than 100 µm. The distance between these ”trabecular” surfaces also appeared to be too large to allow for the formation of a 3D network of
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cellular processes and gap junctions to develop, and would not enable the formation of a
cellular network within the bone matrix itself, as is the case in native bone. The irregular
geometry of this scaﬀold would hinder use of this model in pericellular ﬂow culture studies,
due to the nonuniform ﬂow proﬁle that would result. 61
The ability to utilize a 3D
culture model with a wide variety of cell sources, eventually including human cells, is extremely
important. Bone explant models
oﬀer actual in vivo bone architecture and matrix composition,
cells
and have proven to be capable of Figure 3: SEM images of human endometrial stem
5

supporting both the native osteo-

adhering to the scaﬀold made by Bahrami et al. , comprised of a lyophilized mixture of collagen and HA. c. Scale
bar = 100 µm, d. Scale bar = 50 µm.

cytes and osteoblasts seeded onto
the surface of the explant. 20,90 However, the osteocytes that reside within the bone tissue
cannot be thoroughly removed without compromising that desired architecture and matrix
composition. This limitation hinders the use of osteocytes taken from a knockout animal,
and using bone from knockout animals may result in the explant having very diﬀerent composition or structure compared with a non-knockout control group. In clinical settings, the
presence of native osteocytes in this kind of explant requires the utilization of an individual's
own bone tissue in a graft used for fracture treatment. Moreover, if this type of bone explant
is to be large enough to be easily manipulated for experimental purposes, it must be taken
from larger animal sources, rather than smaller animals such as mice.
Thus, while there are bone cell culture models that include elements necessary to replicate in vivo conditions, each falls short in some regard, or are impractical for implementation
on a wide scale.

1.4

Proposed Work
To ﬁll this gap, a 3D collagen-hydroxyapatite composite cell culture platform for the

culture of osteoblasts must be developed that promotes osteoblast diﬀerentiation to osteo-
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cytes, and allows for the utilization of a variety of cell sources, potentially including a bone
fracture patient's autologous cells in a clinical setting.
ECM Component
The material used to form the non-mineral constituent of the 3D culture should be
biocompatible, capable of binding cells, and consistent and controllable in its stiﬀness following polymerization. Given that it comprises the majority of bone's protein content, type
I collagen is the most promising option. Aside from the appeal of collagen's ﬁdelity to physiological bone composition, it also likely plays some role in the mineralization process. Its
regions of positive net charge promote inﬁltration of collagen ﬁbrils by negatively-charged
calcium phosphate complexes. 72 Additionally, it is distinguished from other commonly-used
hydrogels by causing BSP to be far more potent in HA nucleation. 72,103 Moreover, while
other possible matrix materials, such as alginate, can be modiﬁed with RGD domains, 86
collagen intrinsically contains this amino acid sequence, allowing the matrix to readily bind
cells without the need for additional processing or modiﬁcation. 6 Among types of collagen that can be utilized, oligomeric PSC has easily-modulated mechanical properties, and
can polymerize quickly at a physiological temperature, in contrast with more monomer-rich
varieties of collagen. This facilitates the sustained homogeneity of both mineral and cells incorporated with the collagen until polymerization, without the polymerization temperature
jeopardizing the viability of the cells. 6
With regard to the stiﬀness of the collagenous matrix, Mullen et al. recently assessed
osteoblastic diﬀerentiation in relation to substrate stiﬀness. 66 A majority of the seeded osteoblasts developed an osteocytic morphology when cultured on substrates with stiﬀness in
the range of 9.7 Pa to 286 Pa, whereas few cells adopted such a morphology when cultured on
a substrate with a stiﬀness of 957 Pa. The concentrations of collagen in the 286 Pa substrate
and the 957 Pa substrate were equal, the latter only being more extensively crosslinked.
This indicates that the concentration of collagen in the matrix is not as important for osteodiﬀerentiation as the stiﬀness of the matrix. Gene expression quantiﬁcation showed that
DMP1 was most highly expressed on the 286 Pa substrate. However, the cultures used in
this study were 2D, and thus whether this approximate stiﬀness is also optimal in 3D is
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uncertain. Moreover, the presence of mineral in the matrix may aﬀect the stiﬀness at which
the matrix best induces osteodiﬀerentiation.
Cellular Component
The majority of research aimed toward developing 3D culture systems uses cell lines
with properties similar to the native cells, such as MLO-Y4s or MLO-A5s for osteocytes, 48
and MG-63s, Saos-2s, and U2 OSs for osteoblasts. 8,14,35,94 While these cell lines provide consistency for their respective cell type, their phenotypes can deviate signiﬁcantly from primary
bone cells. Such deviations include the level of expression of integrins, 22 ECM proteins, 8,22
surface antigens, BSP, other proteins important in bone development such as ALP, OPN,
osteocalcin, osteonectin, and osteoprotegrin, 22,77 and even in cell size. Given the incomplete
understanding of the role played by many of these factors in bone cell physiology and bone
tissue formation, there is limited rationale for thinking that results from these studies are
translatable to an in vivo setting. Therefore, the cells used in developing and optimizing an
in vivo-like in vitro model should be primary cells.
Mineral Component
HA, deﬁned by the chemical formula Ca5 (PO4 )3 OH, is a biocompatible calcium-phosphate. 12
Outside of bone, its production requires heating to at least 800 ◦ C. Precipitated hydroxyapatite (PHA) is deﬁned by the chemical formula Ca10-x (HPO4)x (PO4)6-x (OH)2-x , and is what
is obtained by the preparation of HA in an aqueous solution. PHA can be nearly stoichiometrically identical to HA, and it is commonly found in orthopedic cements. Moreover, the
mineral found in living bone is not stoichiometric, so imperfect stoichiometry makes PHA
more comparable to the mineral with which cells would naturally come into contact compared with HA. Thus, with regard to chemical characteristics, PHA would be an optimal
calcium-phosphate for incorporation into the ECM.
Mineralization defects in mice have been associated with increased crystallinity of
the bone mineral, 53 so the recapitulation of healthy bone conditions appears to require
mineral with poorer crystallinity than stoichiometric HA. Indeed, X-ray diﬀraction showed
the crystallinity of mammalian bone mineral to be more comparable to a PHA-like mineral
than to HA. 25 In addition to the biological signiﬁcance and physiological relevance of the
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mineral crystallinity, a ﬁner, less crystalline PHA (hereafter referred to as HA) would be
more easily incorporated into the matrix that would comprise the non-mineral portion of
the extracellular environment in the 3D culture system.

2
2.1

MATERIALS AND METHODS

Porcine Skin Collagen
The PSC solutions were prepared by mixing a stock solution of the collagen in hy-

drochloric acid with additional 0.01 N hydrochloric acid to dilute it, and then with a selfassembly reagent (SAR), comprised of sodium hydroxide for pH neutralization, PBS for
buﬀering, and calcium chloride to initiate polymerization. Quantities of each reagent were
based on prior characterization in which shear moduli of the polymerized solutions were
tested at varying collagen concentrations, from which a curve was determined. 6 In these 3D
culture experiments, concentrations were used that resulted in an expected shear modulus
of 250 Pa and 500 Pa, with average collagen concentrations of 1.6 mg/mL and 2.2 mg/mL,
respectively.

2.2

Preparation of Hydroxyapatite
HA nanocrystals were synthesized using a procedure adapted from Pathi et al. 76 372

mL 10 mM ammonium phosphate (Sigma Aldrich, St. Louis, MO) was added drop-wise
into 620 mL of 10 mM calcium nitrate (Sigma Aldrich, St. Louis, MO), yielding a 1:1.67
molar ratio. The process was carried out in a 1 L round-bottom ﬂask and maintained in
an ice-water bath until 1 hour after all ammonium phosphate was added. The solution was
stirred at room temperature for 12 hours. Throughout the synthesis, the solution was kept
at a pH of 9-9.5 using diluted 1-2% ammonium hydroxide (Sigma Aldrich, St. Louis, MO),
and stirred at 600 rpm using a 15 x 35 mm oval stirring pill.
The solution was transferred to 50 mL tubes, centrifuged at 1,200 rpm and the tubes
decanted, until all excess solution was disposed of. The precipitated HA was rinsed with
0.1 M ammonium hydroxide via vortexing, centrifugation, and decanting, 4-5 times. The
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HA was then rinsed with acetone (Fisher Scientiﬁc, Hampton, NH) using the same method,
twice. Finally, the HA was similarly rinsed with MilliQ water twice, then resuspended in
MilliQ water, and snap-frozen in liquid nitrogen. Within 45 seconds of removal from liquid
nitrogen, paraﬁlm was placed over the frozen tube and punctured several times with a 22gauge needle. The tube was then lyophilized until dry (at least 3 days), yielding the ﬁnal
precipitated HA product. All HA was passed through a 25 µm sieve before use.

2.3

Hydroxyapatite Characterization

HA Particle Size Analysis HA particles

Long
dim.

were measured via TEM imaging after being

Short

passed through the 25 µm sieve.

dim\ ·........./ /

Suspensions

of HA in MilliQ water were prepared from 3

,//'·-.\

/ .../

diﬀerent rounds of synthesis, and placed onto
hydrophilically-charged copper 400 mesh Formvar/Carbon ﬁlm-lined chips (Electron Microscopy

-

10 nm

Sciences, Hatﬁeld, PA). At least 15 individual par-

Figure 4: Individual HA particle under

ticles (separate from particle conglomerates) from TEM. Dotted lines represent dimension (dim.)
each synthesis were imaged using a Tecnai T20

measurements across the particle.

(FIE, Hillsboro, OR), and then measured in ImageJ. Measurements were made of the longest
end-to-end distance across the particles, as well as the shortest distance across, as shown in
Figure 4.
HA Volume Fraction and Surface Area

.....

/

~

Density In-Culture In order to assess the homogeneity of HA distribution within the collagenous
matrix and verify that there would not be signiﬁcant settling of the HA between the time that the

y

/

-

.

O.Scm

□

~x

Top

Middle □
Bottom

Collagen/HA

□
2.5cm

PEEK Mold

/

collagen-HA mixture was added to the culture mold Figure 5: Sideview collagen-HA construct mold.

Red boxes indicate regions

and the time that the collagen ﬁnished polymerizing, scanned for volume fraction analysis. Image
HA was mixed into 250 Pa PSC solutions at either 14

not to scale.

mg/mL or 28 mg/mL concentrations, and 0.5 mL were then added to a mold with the same
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dimensions as the ones used for 3D culture (2.5 cm x 0.5 cm), but with one side consisting
of a glass coverslip sealed to the mold using petroleum jelly (Figure 5). The samples were
imaged through the coverslip using a Nikon A1R-MP confocal microscope (Nikon, Melville,
NY) in reﬂectance mode (514.5 nm laser wavelength). 636.4 x 636.4 µ image stacks, 40 µmthick, were taken at a 0.25 µm z-axis interval (reconstructions in Figure 6). Mineral in the
image stacks was thresholded in ImageJ using Otsu's method, and then counted using the
3D Object Counter plugin, which provided measures of object volumes and surface areas.
The resulting total object volume was divided by the known total volume of the image stack
to ﬁnd the volume fraction. HA volume fractions and surface areas were compared between
14 mg/mL and 28 mg/mL conditions, and between the top, middle, and bottom regions of
the construct via ANOVA and post-hoc testing by Duncan's new multiple range testing.

(a) 14 mg/mL HA

(b) 28 mg/mL HA

Figure 6: Confocal stack reconstructions of HA suspended in 250 PA PSC solutions. 40 µmthick stacks were scanned in reﬂectance mode, and then analyzed in ImageJ to determine the volume fraction
occupied by HA and the amount of exposed HA surface area per volume. Scans shown in this ﬁgure were
taken from the middle regions of the samples. Scale bars = 100 µm.

2.4

Cell Source
In order to identify cell phenotype while imaging cells in situ, without needing to

section or stain the culture, it is desirable to have a cell model that endogenously expresses
ﬂuorescent indicators of cell diﬀerentiation. Therefore, mice homozygous for an mT/mG
sequence, 68 located on the ubiquitously-expressed ROSA26 locus of chromosome 6, were
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crossed with mice heterozygous for Cre recombinase expressed under control of the DMP1
promoter (DMP1-8kb-Cre). 56 The mT/mG sequence contains a loxP-ﬂanked membranetagged tandem dimer Tomato and a stop codon, followed by a downstream membrane-tagged
enhanced green ﬂuorescent protein (eGFP). Upon expression of Cre recombinase, the region
ﬂanked by loxP sites is removed, and the adjacent sites on the locus are attached. Thus,
cells in DMP1-8kb-Cre-positive mice resulting from this cross ubiquitously express Tomato,
and ﬂuoresce red, except where the promoter for DMP1 is active, and Cre recombinase
is produced, resulting in the cells ﬂuorescing green. This genotype therefore provides not
only endogenous ﬂuorescence for bone cells, but also indicates cell phenotype during the
diﬀerentiation of osteoblasts into osteocytes, the osteoblasts ﬂuorescing red until they become
osteocytic and begin the production of eGFP.

2.5

Cell Culture

Cell Isolation from
Murine Long Bones and

DMPl Cre
95 bp Exon 1
9.6 kb DMPl Promoter

First 17 bp Exon 2
CrecDNA ➔

pA

2D Cell Culture Cells
were isolated from male and
female mice aged 6-8 weeks,

Within bone, activity exclusive
to late osteoblasts and
osteocytes.

mT/mG
sequence on
ROSA26

using a protocol modiﬁed
from Stern et al. 89 . Mar- Figure 7: DMP1-8kb-Cre x mT/mG Model. Under control of
row was ﬂushed from the the DMP1 promoter, cells express Cre recombinase, which cleaves the tD
femora, tibiae, and humeri

tomato-transcribing region from the ROSA26 locus, causing the cell to
cease tD tomato expression and begin eGFP expression. pCA- enhancer,
pA- polyadenylation sequence following stop codon 68,93

using a 25-gauge syringe
(BD, Franklin Lakes, NJ) and Alpha MEM (Fisher Scientiﬁc, Hampton, NH), which were
then cut into chips and digested in solutions of 300 AU/mL collagenase (Sigma Aldrich, St.
Louis, MO) and 5 mM EDTA (Sigma Aldrich, St. Louis, MO) to obtain osteoblasts. Cells
were plated onto 10 cm petri dishes coated with 450 µg type I collagen (Corning, Corning,
NY). Marrow cells were plated at 3.3 x 107 cells/dish, and osteoblasts were plated at 2-3 x
106 cells/dish. Cells were cultured with 8-9 mL of complete culture medium composed of
89% Alpha MEM (Fisher Scientiﬁc, Hampton, NH), 10% FBS (Atlanta Biologicals, Flowery
Branch, GA), and 1% Pen Strep (Fisher Scientiﬁc, Hampton, NH). The MSC medium was
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changed after 7 days. In the osteoblast cultures and after the ﬁrst medium change in the
MSC cultures, all but 1-2 mL of the medium was changed every 5-7 days.
Isolated Cell Characterization To determine which digestion steps during the cell
isolations would be used in cell culture, 10 µL cell suspensions were taken from each digest, placed onto a glass slide, and sealed under a coverslip. Cell samples were imaged via
epiﬂuorescent microscopy using an Olympus IX71 inverted microscope (Shinjuku, Tokyo)
under plain light, as well as under FITC and TRITC ﬁlters. Cells were counted via ImageJ,
using the following criteria: a cell was deemed ”yellow” if there was mixing of red and green
coloration within a cell, or if a cell was partially red and partially green; a cell was deemed
”red” if it was only red, or if green signal was present in less than 10% of the cell body; and
a cell was deemed ”green” if the cell was only green, or if any red signal was present in less
than 10% of the cell body.
3D Culture Dish 3D cultures were kept
in a dish (Figure 8) made from polyether
ether ketone (PEEK), a thermally resistant,
biodegredation-resistant, biocompatible polymer. 65,84,100 The dish was made up of two
halves, between which there was a microporous
(0.45 µm) nylon membrane layer over a silicon
gasket, with holes cut to align with 10 roundended, 1 cm-wide slots in the PEEK dish. The
top and bottom halves of the dish were secured Figure 8: 3D Cell Culture Dish Figure shows
together with screws. The bottom half of the cultures at 56 days just prior to processing. Samples shown in ﬁgure include: 1,2.

500 Pa 14

dish was partially elevated and slotted such mg/mL osteoblasts; 3. empty; 4-6. 500 Pa 28
mg/mL osteoblasts; 7. empty; 8. 500 Pa 14 mg/mL

that the underside of the 3D cultures would non-cellularized control; 9,10. 500 Pa 28 mg/mL
be accessible to the culture medium. All dish

non-cellularized control.

components were autoclaved prior to use with cells. When used for cultures, the PEEK dish
was kept in a 25mm-tall 10 cm petri dish.
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3D Culture Parameters Within a collagenous 3D matrix, osteoblast-like MG-63 cells
have previously been found to have the greatest proliferation, initial Alp transcription, and
increase in Runx2 and Sparc (an indicator of mineralization 9,74 ) with initial seeding densities
of 6 x 105 - 3 x 106 cells/cm3 . 10 3D cultures were therefore seeded at a density of 1.5 x 106
cells/cm3 . HA concentrations exceeding 28 mg/mL were diﬃcult to mix into PSC solutions,
so the high-HA culture condition was 28 mg/mL, with a low-HA concentration of 14 mg/mL,
and 0 mg/mL as a control group. Dexamethasone is commonly used to supplement osteogenic
(OG) culture medium, due to its acceleration of osteodiﬀerentiation in MSCs. 83 However, it
is not naturally-occurring, promotes apoptosis in osteocytes and osteoblasts 73,97 , and impairs
osteoblastogenesis. Dexamethasone was therefore omitted from the OG medium. Included
in the OG medium were the common OG medium components β-glycerophosphate, a source
for the phosphates used in bone mineral formation, and ascorbic acid, which enhances the
expression of several osteoblast-speciﬁc genes. 32
3D Cell Culture Preparation Quantities of HA for the 3D cultures were measured
into 2 mL tubes, and subjected to at least 20 minutes of ultraviolet light for sterilization.
Prior to the collection of cells from 2D culture, they were observed using the microscope and
ﬁlters used for the isolated cell characterization, and pictures were taken for colorimetric
diﬀerentiation analysis. Primary osteoblast cultures were only used in 3D cultures if at
least 95% of the ﬂuorescent cells were red. The cells were trypsinized, pooled into a single
suspension, and counted using a hemacytometer (Hausser Scientiﬁc, Horsham, PA). The
desired quantity of cells were added to sterile 1.7 mL tubes, and microcentrifuged at 1,200
rpm for 3 minutes, rotated 180 degrees, and then microcentrifuged again for 2 minutes.
The supernatant in the tubes was aspirated, and the pellets disrupted via tapping against a
bench. PSC solutions were prepared, using reagents in proportions calculated for either a 250
Pa or 500 Pa shear modulus in the polymerized matrix, and the cell pellets suspended to to
homogeneity in the PSC solutions such that no distinct pieces of the pellet were visible. If the
sample included HA, part of the PSC solution was reserved to homogenize with the prepared
HA. The resulting mixture was then added to the cell suspension and homogenized. The ﬁnal
mixture was pipetted into the PEEK dish, at a volume of 0.5 mL per slot. The dish was then
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incubated at 35 ◦ C for 10-15 minutes, before having 1-2 mL culture medium added to the top
side of the cultures in each of the slots. Approximately 30 mL of medium were then added
to the bottom of the petri dish, and the ends of the dish lifted and dropped with a pipette
tip to remove any air bubbles trapped below the bottom of the mold. Cultures carried out
to 28 or 56 days were switched to osteogenic culture medium composed of complete medium
with 5 mM β-glycerophosphate (Sigma Aldrich, St. Louis, MO) and 50 µg/mL ascorbic
acid (Sigma Aldrich, St. Louis, MO) on day 3 of the culture period. All but 10 mL of the
osteogenic medium was changed every 4-6 days thereafter. Medium residing on top of the
3D cultures was changed to the extent possible without disrupting the cultures during the
vacuuming process.

2.6

3D Culture Sample Collection and Analysis

Culture Processing At the end of each

Confocal Imaging

culture period (3, 28, or 56 days), medium
was removed from the cultures, and the cul-

Mechanical
Testing

Mechanical
Testing

µCT

tures and dish were rinsed with DPBS (Lonza, Figure 9: Allocation of 3D culture portions
during processing. Total culture width was 2.5

Walkersville, MD) twice. 4 mm-wide sections cm. Measurements of sections were 4 mm wide for
for mechanical testing were then cut from each the mechanical testing samples, 0.6±0.05 mm for
the confocal imaging samples, and the remainder for

culture using a scalpel, in duplicate, and kept µCT samples, later cut to 4 mm widths before use.
in room-temperature MilliQ water until use, within 6 hours of harvest. The PEEK dish was
then transferred to a beaker of 4% PFA (Sigma Aldrich, St. Louis, MO) and ﬁxed for 75
minutes, after which the dish was rinsed in beakers of MilliQ water twice, kept in each for 5
minutes, in order to remove residual PFA. Razor blades attached in parallel using 5-7 layers
of double-sided tape, with a distance of 0.6-0.75 mm between the cutting edges, were used to
cut at least 2 sections from each culture, which were transferred to a glass coverslip with a
silicon gasket (0.54 mm thick) spanning the perimeter. Mounting medium with DAPI (ProLong Diamond Antifade Mountant, Thermo Fisher Scientiﬁc, Waltham, MA) was added to
the sections, and another coverslip was placed onto the samples and gasket. The resulting
slide was left in the dark at room temperature for 3 days, before being stored in the dark
in a refrigerator. What remained of the culture samples was transfered to 2 mL tubes ﬁlled
with 70% ethanol and refrigerated until used for µCT scanning.
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Imaging and Fluorescent Cell Counting Prepared slides were imaged via confocal
microscopy, using 561 nm, 488 nm, and 408 nm lasers, to detect Tomato, eGFP, and DAPI,
respectively, using a Nikon A1R-MP confocal microscope (for samples with DAPI), or a
Nikon A1Rsi confocal microscope (Nikon, Melville, NY), equipped with an air-immersion
Plan Apo 20x DIC objective lens. 318 µm x 318 µm image stacks at 2 µm z-axis intervals
were taken for 100 µ-thick regions in non-mineralized samples and 40-60 µ-thick regions in
the mineralized samples (n ≥ 3 stacks per sample). Signiﬁcant interference at or beyond
a depth of approximately 25 µm into the sample limited the imaging depth in cultures
containing synthesized HA. Gain and laser intensity were adjusted to keep the signal just
below saturation, and z-corrected to maintain that level of signal. Laser intensity and gain
settings at the bottom of the stacks were approximately 11% and 85, 13% and 79, and 10%
and 75 for the red, green, and blue channels, respectively. Laser intensity and gain settings
at the top of the stacks were approximately 18% and 95, 17% and 83, and 16.5% and 89 for
the red, green, and blue channels, respectively. The ﬁlter cubes used were 450/50, 525/50,
and 595/50. The pinhole size was 47 µm. Images were averaged from 2 scans per z-position
to reduce noise. The channel series function was used, in order to prevent bleed-through
between channels.
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(a)

(b)

(c)

(d)

(e)

(f )

(g)

Figure 10: Representative cells observed in MaxIPs from confocal stacks of a 56-day 500 Pa
14 mg/mL osteoblast culture. a) Grouping of cells b) Red cell. c) Yellow cell. d) Green cell. e) Yellow
cell (arrow) approaching green coloration, counted as ”yellow” in colorimetric data. f ) Cell ﬂuorescing both
red and yellow, counted as ”yellow” in colorimetric data. g) Cell ﬂuorescing both red and green, counted as
”yellow” in colorimetric data.
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Image stacks were then converted to maximum intensity projections (MaxIPs) for cell
counting. Counts were performed manually in ImageJ, using the same color classiﬁcation
scheme as with the isolated cell characterization (examples shown in Figure 10). To conﬁrm
continued cell presence throughout the culture period, DAPI-stained cell nuclei were counted
in each MaxIP, and the number in each divided by the volume scanned in that image to
determine cell density. Data were analyzed in SPSS Statistics 24 (IBM, North Castle, NY)
via one-way ANOVA and Tukey post-hoc testing.
µCT Scanning and Analysis Samples were cut to 4 mm in

1000

length, and transferred to 1 mL Lu-

800

- -2SO Pa 1
- -250Pa2

- -2S0Pa3

ii,

- -250Pa4

- -2SO PaS
- -250Pa6
- -SOOPa 1
- -500Pa2
- -500Pa3
- -500Pa4
- -SOOPaS

,:,

gol iodine solution 21 (Sigma Aldrich,
St.
hours.

Louis, MO) for at least 3
Iodine-soaked samples were

C:
111

"':::,
0

.c:

!::.

]"'
C:

then wrapped in paraﬁlm without
being compressed, and placed into

-800

-300

200

700

1200

1700

Hounsfield Units (HU)

a radio-transparent polyetherimide Figure 11: µCT Histograms for Thresholding Vertical
(ULTEM) column. The column was line at 1428 HU represents the average signal intensity for
which there were 20 or fewer pixels.

then loaded into a Scanco uCT 40
(Scanco, Brttisellen, Switzerland) and scanned (45 kVp, 177 µA, 10µm/voxel). Scans were
contoured manually to deﬁne the boundaries of each culture. 3-day non-cellularized 0 mg/mL
HA constructs with either 250 Pa PSC (n=6) or 500 Pa PSC (n=5) were scanned to provide
a baseline attenuation threshold for the collagen matrix. The upper end of each collagen
attenuation curve was deﬁned as the highest Hounsﬁeld Unit (HU) value that included at
least 20 voxels (Figure 11). Averages for these thresholds for the 250 Pa and 500 Pa collagen constructs were 1347±72 HU and 1508±228 HU, respectively. The threshold values for
the two collagen concentrations were not signiﬁcantly diﬀerent (p > 0.05 student's t-test).
As the 56-day 20-pixel threshold (1324±216) for n=3 0 mg/mL 250 Pa PSC constructs was
statistically similar to that of the 3-day samples, it was determined that shift in threshold
with culture time did not have to be taken into consideration. A value of 1428 HU was
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applied to all cultures to diﬀerentiate mineralized from non-mineralized tissues in the 3D
cultures in order to assess mineral volume/total volume (MV/TV) and the apparent and
tissue mineral densities.
Mechanical Testing Samples cut from the cultures were tested using a servoelectric
material testing system (Bose, Eden Prairie, MN), equipped with a 40 N load cell. These
samples were ﬁrst measured for thickness, and placed onto a ﬁberglass platen. The top
platen was brought to the sample's measured thickness above the bottom platen, or until
a steady compressive force of 0.001 N was detected by the load cell. The sample was then
compressed to 80% strain, at a rate of 17% strain/second. The calculated compressive stress
was obtained by dividing the compressive force by the calculated base area of the section
(4 mm x 5 mm). Stress/strain slopes were then calculated for the 0-4% and 40-60% strain
regions.

3
3.1

RESULTS

Mineral Characterization

Particle Size Analysis While
120

the individual particle measures varied widely within each batch of precipitated HA, (Figure 12), the aver-

E

90

□

First Batch

■

Second Batch

■ Third

.=.

Batch

□ overall

..c: 60

b.O
C:

age particle dimensions were similar between batches (63±26 nm and 25±9

~

30

0

Long Dimension

Short Dimension

nm). The small particle size should pre- Figure 12: HA particle dimensions for 3 indepenvent the HA from interfering with the dent batches of precipitated HA. Across-batch ANOVA
polymerization of the PSC matrix and

p > 0.05. Data are mean particle dimensions +1SD. ”Overall” represents a mean of the 3 sets +1SD. n-values of individual crystals measured are indicated in data bars.

leave cells free to extend processes toward other cells, without needing to circumnavigate approximately cell-sized particles, as a
part of the early stages of developing a lacunocanalicular network. There is also evidence
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that osteoblasts cultured with nanoscale HA particles proliferate more readily than with
microscale HA particles. 39
HA Volume Fraction and Sur-

verify diﬀerences in the volume occupied by HA for the diﬀering HA concentrations (14 mg/mL or 28 mg/mL)
used in the construct preparation, and

-

30

face Area Density Analysis To
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to test for consistent volume occupied
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by HA throughout the culture, a 2- Figure 13: Volume fraction by construct depth in 250
Pa 14 mg/mL and 258 Pa 28 mg/mL matrices. Data

way ANOVA test was performed. Vol- are mineral volume/total volume means +1SD from scans of
n=3 constructs. Horizontal bars indicate p < 0.05 between

ume fraction was used as the depen- 14 mg/mL and 28 mg/mL.
dent variable, and HA concentration and vertical position were set as the independent variables.
There was a signiﬁcant diﬀerence
in the volume fraction occupied by HA
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between the 14 mg/mL and 28 mg/mL
samples (13.4±0.6% vs 24.3±0.4%),
but not between diﬀerent vertical posi-
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tions within a HA-collagen construct.

0

Bottom
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For added protection against type II Figure 14: HA surface area densities in 250 Pa 14
mg/mL and 250 Pa 28 mg/mL matrices. Data are HA
surface
area/total volume means +1SD from scans of n=3
error in testing volume fractions beconstructs. Horizontal bars indicate p < 0.05 between 14
tween vertical locations, Duncan's new mg/mL and 28 mg/mL conditions.
multiple range test was utilized. This, too, found the diﬀerence in volume fraction between
all vertical locations to be statistically similar.
Total object surface areas per total stack volume were measured and compared between
vertical levels and between diﬀerent HA concentrations (Figure 14). As with the volume
fraction measurements, there were no signiﬁcant diﬀerences in HA surface area density between the vertical locations, while there was a signiﬁcant diﬀerence in surface area density
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between the 14 mg/mL and 28 mg/mL conditions (0.196±0.008 µm2 /µm3 vs 0.361±0.019
µm2 /µm3 )

3.2

Cell Characterization

Based on the samples collected, it
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Qi
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Digest Step

large number of green cells. All di- Figure 15: Colorimetric data from cell isolation chargests thereafter predominantly con- acterization. Data are means +1SD from n = 5 isolations.

Most of the cells obtained in each step were red or yellow,

tained red and yellow cells (Figure with few green cells, indicating a predominantly osteoblastic
or late-osteoblastic phenotype.

15). Stern et al. found that cells from
digests 7-9 expressed the early osteocyte marker E11/GP38, and found ALP-positive cells in
the minority in those steps. 89 Thus, all cell isolations following this characterization utilized
only digests 3-6, as this was concluded to provide the purest population of osteoblasts.

3.3

Diﬀerentiation Analysis
Within osteoblast cultures, proportional red cell number declined (Figure ??), indi-

cating a loss of osteoblastic cells due to shift toward osteocytic phenotype. From 3-day time
point to the 56-day time point, this was most signiﬁcant in 250 Pa 14 mg/mL conditions,
but this was in part because the other conditions had a lower proportion of red cells by the
3-day time point.
Yellow cell proportions among osteoblast cultures, suggesting late osteoblasts or early
osteocytes, increased most signiﬁcantly in the 250 Pa 14 mg/mL conditions, although this,
too, was in part due to the other conditions having a greater number of yellow cells by
3-days.
250 Pa PSC 28 mg/mL HA and 500 Pa PSC 28 mg/mL HA culture conditions showed
signiﬁcant increases in green cells during the culture period. All culture conditions had
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Green Cells in 3D Culture
("Osteocytes")
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Figure 16: Cells in 3D culture as a percentage
of all cells counted per image. Data in graphs represent mean percents +1SD for either green (i.), redgreen (yellow) (ii.), or red (iii.) cells in culture, presumed to be mature osteocytes, late osteoblasts/early
osteocytes, and osteoblasts, respectively. Solid bars indicate p < 0.05 between day-3 and day-56. Diﬀerent upper-case letters indicate p < 0.05 at 56 days.
There were no signiﬁcant diﬀerences between groups
at 3 days. n-values indicated in data bars.
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28mg
500 Pa PSC

signiﬁcant shifts in cell colorations from what was measured in 2D conditions just prior to
the cells going into 3D culture.
Cell density, determined by the

3D Culture Cell Density

number of DAPI-stained nuclei counted

1.6E+07

in MaxIP images divided by the scan vol-
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(Figure 17), was higher in all culture
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conditions and at all time points than

0.0E+00

Mq

the initial seeding density of 1.5 x 106
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~~

250 Pa PSC Culture Condition 500 Pa PSC

Figure 17: Cell density in 3D cultures remained

cells/mL. Cell density remained consis- consistent between culture conditions and time
tent throughout the culture period (8,980 points. 6 Dashed line indicates the initial cell density of
1.5 x 10 cells/mL at the time of 3D culture formation.

cells/mm3 ), and did not diﬀer between 3- Means +1SD. n-values indicated in data bars.
day and 56-day samples by t-testing (p ≥ 0.57) or between culture conditions at a given time
point. This likely indicates rapid initial cell replication upon entering the 3D collagen-HA
environment, until a density is reached that becomes inhibitory for further mitotic activity.
Some cell nuclei showed a morphology indicating apoptosis, but these were in the minority.
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3.4

µCT Analysis
A 3D culture model that eﬀectively recapitulates the in vivo environment of osteocytes

and osteoblasts such that they form new bone tissue will result in increased mineral density
during the culture period.
Mineral Volume Fraction
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Figure 18: µCT analysis
showed mineral formation
in most culture conditions
made with HA, but not in
cultures made without HA.
Mean+1SD. n-values are indicated in data bars. Horizontal
bars indicate p < 0.05 between
14 mg/mL and 28 mg/mL. (2tailed t-test) Diﬀerent uppercase letters indicate p < 0.05
at 56 days (one-way ANOVA).
There were no signiﬁcant diﬀerences between groups at 3 days.

Measured MV/TV (Figure
18) indicate that greater starting
mineral content (28 mg/mL) induced
in situ mineral formation from 3- to
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(500 Pa). While to a lower extent,
cultures with lower starting collagen
content and mineral content (250 Pa
PSC and 14 mg/mL HA) did show an
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upward trend (p < 0.09) in mineral
content over the culture period, and
there were visible changes in the 3D
culture constructs (Figure 19). The

500 Pa PSC
14 mg/ml HA

250 Pa PSC
28 mg/ml HA

Figure 19: Reconstructions from µCT scans.

cultures without any starting mineral, however, showed no detectable increase in mineral content.
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3.5

Mechanical Testing
A 3D extracellular matrix condition that promotes osteoblast diﬀerentiation to osteo-

cytes will result in DMP1 secretion into the matrix. This DMP1 should then induce de
novo formation of bone mineral, and impregnation of collagen ﬁbrils with HA, leading to
the culture construct becoming increasingly stiﬀ.
Preliminary data (not shown) using MSCs in 3D culture demonstrated no detectable
change in the cultures' compressive stiﬀness over a 56-day culture period. Therefore, only
osteoblasts were used for further 3D cultures. Likewise, osteoblast cultures prepared without
HA showed no detectible changes in compressive stiﬀness.
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Figure 20: Compressive moduli at low and high compressive strains for the various 3D culture
conditions examined regions. Means +1SD. n-values indicated in data bars. Diﬀerent lower-case letters
indicate p < 0.05 at 3-days. (one-way ANOVA) Horizontal bars indicate p < 0.01 between 3- and 56-days.
(2-tailed t-test)

The compressive modulus at low strain (Figure 20a) did not signiﬁcantly increased
over the course of the 56-day culture period in any of the cultures. While not signiﬁcant,
however, there was an upward trend (p < 0.09) in both 500 Pa PSC culture conditions. The
250 Pa PSC, 28 mg/mL HA condition resulted in a downward trend, but this is suspect, in
light of the sample standard deviation for that 56-day time point exceeding the mean for
that time point.
At higher strain (Figure 20b), 3-day culture modulus reﬂected the concentration of
HA they were prepared with. There was generally an increase in stiﬀness for all culture
conditions in the higher strain region, but this was only signiﬁcant in the cultures made with
500 Pa PSC.
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4

DISCUSSION

This 3D in vitro culture system constitutes a novel means of culturing cells in a
collagen-HA composite matrix, and measuring phenotypic, compositional, and structural
indicators of cell diﬀerentiaiton and bone formation. The primary osteoblasts in culture
were successfully sustained and diﬀerentiated to late osteoblasts and osteocytes. This differentiation was accompanied by de novo bone mineral formation, and alterations in culture
mechanical properties at high strain.
The DMP1-8kb-Cre x mT/mG mouse model used provides an eﬀective means of visualizing cells and characterizing cell phenotype in situ within this 3D culture model. Unlike
more conventional staining methods, this visualization can be done using live cells, allowing
for real-time monitoring of cell diﬀerentiation in a single sample using an appropriatelydesigned culture mold. Colorimetric diﬀerentiation data both in the isolation step characterization and in the 3D culture section imaging may be limited in accuracy by the imperfect
nature of the DMP1-Cre system. Cre has been measured to be anywhere from 60% to 90%
eﬃcient 51,104 , and thus there could be up to 66% more osteoblasts that actually underwent
diﬀerentiation to osteocytic than were identiﬁed. To supplement colorimetric analysis of
confocal images in identifying diﬀerentiation in situ, samples that have been used for µCT
thus far will be used for histology, and stained using antibodies for DMP1, as well as the
diﬀerentiation markers Sclerostin, Runx2, and FGF-23. In addition, they will be stained
with Goldner's trichrome to detect de novo mineral formation.
To further oﬀset this uncertainty, and to better compare these results with those of
other existing models, it would be useful to repeat cultures for gene expression analysis in
order to both have a more certain quantiﬁcation of changes in Dmp1 transcription with time,
as well as other osteodiﬀerentiation marker genes such as E11/gp38, Sost, and Runx2. This
analysis was not performed on the samples tested thus far due to low measured RNA yield
in preliminary studies, and the need for nearly half of the culture construct for mechanical
testing samples. Future cultures made for this purpose would utilize the majority of the
culture volume for RNA isolation. A small portion would be allocated for µCT analysis so
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that the culture can be conﬁrmed as comparable with cultures in the existing dataset.
Confocal imaging of the more mineralized samples proved more diﬃcult, due to the
interference of the HA with laser excitation of the cells or ﬂuorescent emission from the
cells, thus requiring a greater laser intensity to be used and resulting in a weaker, less clear
signal to be obtained. Multi-photon (MP) microscopy proved less eﬀective in penetrating the
HA in culture than confocal, and showed a greater degree of autoﬂuorescence. Methods for
optical clearing of the imaging samples could be explored, having previously proven viable
for physiological bone tissue. 70 If successful, this could result both in better visualization
of the desired cells being imaged, and reduced visual obstruction by the autoﬂuorescent
mineral surrounding the cells. MP microscopy was also less eﬀective in exciting the red and
green ﬂuorescent proteins without also exciting the DAPI-stained nuclei, so confocal imaging
presently appears to be still be the most eﬀective means of in situ ﬂuorescent imaging volumes
of these cultures.
Mineral content within the 56-day cultures was comparable for the cultures made with
the higher HA content (28 mg/mL) and/or the higher PSC content (∼2.2 mg/mL), each
also showing a marked increase from the mineral content at day 3. The 14 mg/mL HA
with ∼1.6 mg/mL PSC may likewise show a signiﬁcant increase over the 56-day period with
a greater number of replicates, but presently does not appear to reach the same range of
MV/TV values. The lack of any detectable changes in mineral content in the cultures made
without HA supports the prior evidence of a role of HA in osteogenic diﬀerentiation and in
vivo-like gene expression seen by Yin Hsu et al., and indicates that HA is vital in causing
osteoblasts and osteocytes to behave in a physiological manner. To further investigate the
bone mineral formed in each culture condition, histology will be necessary, as the µCT can
only speak to quantity of the mineral, and not its quality. Moreover, in vivo-like bone growth
will involve the formation of a lacunocanalicular system in the mineralized cultures, which
requires sub-micrometer-scale visualization not possible with µCT.
Mechanical properties of cultures strained in the low elastic deformation range showed
no signiﬁcant increases for any condition. Slight ﬂaws in the calibration of the load cell
(0.001 N order of magnitude for force and 0.001 mm order of magnitude for displacement)
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make the calculation of compressive modulus at these strains more prone to inaccuracy than
in the higher-strain regions. Alterations in mechanical properties by cellular activity were
signiﬁcant toward the high end of the linear stress-strain region, but only in cultures made
with a greater quantity of PSC. Similar compressive testing has only been done elsewhere
in the context of bioglass cultures, 58 and is therefore not directly comparable, although
a similar pattern in the stress-strain curves was observed, in which there was a low-stress
region for the ﬁrst half of the loading, followed by an exponential increase in stress per strain
began roughly halfway though. Mineral quantiﬁcation via µCT data to accompany these
mechanical testing data were not obtained.
While the greater surface exposure to HA in the cellular environment may play a role
in the greater mineralization at 56 days seen in the 28 mg/mL cultures, it's also possible
that this diﬀerence was the result of HA limited the mobility of collagen ﬁbrils following
polymerization. MSC diﬀerentiation has previously been found to be aﬀected by substrate
stiﬀness, 82,91,92 and so it is likely that osteoblasts would respond to ECM properties in a
similar manner. Anecdotally, the 28 mg/mL cultures were less prone to peeling oﬀ of the
sides of the wells in the culture dish, were less prone to damage during handling following
the culture period, and were thicker than their 14 mg/mL counterparts. This suggests HA
concentration-dependent contraction of the matrix, with the initial HA content serving as
something of a template or scaﬀold for the matrix. This would support the hypothesis that
the collagen ﬁbrils were less free to move or contract in matrices with greater initial HA,
leaving them more taut and having the eﬀect of being stiﬀer at the level of cellular interaction.
Atomic force microscopy (AFM) testing would be required to conﬁrm this, however.
For comparisons of cell diﬀerentiation and ECM-alteration outcomes with some of the
more similar 3D culture models, such as a bed of biphasic calcium phosphate particles, 13 , or
a lyophilized form of collagen-HA composite, 5 , additional work yielding gene expression and
histological data will be required. The formation of canaliculi is expected to be greater in
this culture model than in Boukhechba et. al’s due to the smaller particle size of the mineral
used (< 25 µm vs 40-80 µm), and the initial collagen content which should facilitate cell
navigation within the culture and possible mechanical signaling.

27
If this model is to be useable for a clinical setting, dipose-derived stem cells (ASCs)
derived from a patient's fat tissue would be a far more readily-available cell source than
osteoblasts obtained from pieces of the patient's bone tissue. ASCs have previously proven
successful in facilitating treatment of cranial bone defects in both canine 27 and human 50
patients. Therefore, a method should be pursued to induce osteodiﬀerentiation of ASCs
into mature to osteoblasts and osteocytes, and subsequent mineralizing of the surrounding
matrix. Due to the lack of observed osteodiﬀerentiation in MSC cultures using this current
culture method, dexamethasone may be used to supplement osteogenic medium used in ASC
cultures prior to incorporation into 3D culture, or for an early portion of the 3D culture
period.
An additional signiﬁcant in vivo element of bone cell activity is pericellular ﬂuid ﬂow.
Bioreactor models subjecting bone cell cultures to ﬂuid ﬂow shear stress (FFS) have primarily utilized 2D cultures, 55 and either bone explant or lyophilized collagen scaﬀold 3D
models. 18,20,80 The use of bulk hydrogel models, on the other hand, has been limited, and
has not included hydroxyapatite. Mechanical stimulation has osteocyte-protecting eﬀects in
vivo 79 , and inhibits the osteocyte apoptosis observed in static cultures. 18,20
This culture model provides a means of recapitulating the physiological setting of bone
cells, and oﬀers a platform in which to study the response of osteoblasts and osteocytes
to chemical and mechanical stimuli. To be more useful in a research or clinical setting,
methods should be pursued to accelerate the cell diﬀerentiation and mineral formation seen
thus far in the 56-day cultures, so that similar results may be achieved in a shorter, more
practical timespan. Some have used osteogenic culture medium with 20% FBS rather than
the 10% used here, and the added growth factors present in the greater quantity of serum
could enhance the diﬀerentiation of osteoblasts in this culture model. Supplementation
of the medium with calcium has proven eﬀective in inducing ECM mineralization by cells
of osteoblastic lineage, and could overcome a potential supply-based rate-limiting step in
the formation of calcium-phosphate mineral being generated by cellular activity. 71 While
glucocorticoids such as dexamethasone are destructive to osteocytes in large doses 28,49,78 or
with chronic exposure 60,96–98 , brieﬂy (approximately 3 days) or intermittently supplying the
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cultures with dexamethasone could cause faster osteogenic diﬀerentiation. In contrast with
conventionally binary presence or absence of dexamethasone during the osteogenic culture
period (normally following day 3 of culture), medium could be put through the culture that
alternately contains or lacks dexamethasone. There could even be varying quantities of
dexamethasone contained in this medium, in order to reﬂect the physiological variation in
serum glucocorticoid concentrations with the circadian clock. 29
The novel 3D in vitro culture system presents a useful platform for future biological
research to investigate how bone cells respond to chemical and mechanical stimuli in an in
vivo-like setting, and a common testbed for cells from diﬀering cell lines or primary cell
sources. It enables a wide array of culture outcome that can be readily assessed, from the
gene expression level to the structural and mechanical level. Moreover, it may serve as a
useful tool for clinical treatments after further trials and investigation, furthering progress
in the ﬁeld of applied tissue engineering.

29

REFERENCES
[1] 2016. EPAR summary for the public: Forsteo. Technical report. European Medicines
Agency. London.
[2] Addison WN, Azari F, Sørensen ES, Kaartinen MT, McKee MD. 2007. Pyrophosphate
inhibits mineralization of osteoblast cultures by binding to mineral, up-regulating osteopontin, and inhibiting alkaline phosphatase activity. Journal of Biological Chemistry
282:15872–15883. doi:10.1074/jbc.M701116200.
[3] Amrein K, Amrein S, Drexler C, Dimai HP, Dobnig H, Pfeifer K, Tomaschitz A, Pieber
TR, Fahrleitner-Pammer A. 2012. Sclerostin and its association with physical activity,
age, gender, body composition, and bone mineral content in healthy adults. The
Journal of Clinical Endocrinology and Metabolism 97:148–54. doi:10.1210/jc.20112152.
[4] Arai N, Ohya K, Kasugai S, Shimokawa H, Ohida S, Ogura H, Amagasa T. 1995.
Expression of bone sialoprotein mRNA during bone formation and resorption induced
by colchicine in rat tibial bone marrow cavity. Journal of Bone and Mineral Research
10:1209–17. doi:10.1002/jbmr.5650100811.
[5] Bahrami N, Malekolkottab F, Ebrahimi-barough S, Tabari ZA, Hamisi J, Kamyab
A, Ai A, Bayat F, Bahrami N, Ai J. 2016.

The eﬀect of purmorphamine on

diﬀerentiation of endometrial stem cells into osteoblast-like cells on collagen /
hydroxyapatite scaﬀolds.

Artiﬁcial Cells, Nanomedicine, and Biotechnology doi:

10.1080/21691401.2016.1236804.
[6] Bailey JL, Critser PJ, Whittington C, Kuske JL, Yoder MC, Voytik-Harbin SL. 2010.
Collagen oligomers modulate physical and biological properties of three-dimensional
self-assembled matrices. Biopolymers 95:77–93. doi:10.1002/bip.21537.
[7] Bekker PJ, Holloway DL, Rasmussen AS, Murphy R, Martin SW, Leese PT, Holmes
GB, Dunstan CR, Depaoli AM. 2004. A Single-Dose Placebo-Controlled Study of AMG

30
162, a Fully Human Monoclonal Antibody to RANKL, in Postmenopausal Women.
Journal of Bone and Mineral Research 19:1059–1066. doi:10.1359/JBMR.040305.
[8] Benayahu D, Shur I, Marom R, Meller I, Issakov J. 2001. Cellular and molecular
properties associated with osteosarcoma cells. Journal of Cellular Biochemistry 84:108–
114. doi:10.1002/jcb.1270.
[9] Bianco P, Silvestrini G, Termine JD, Bonucci E. 1988. International Immunohistochemical Localization of Osteonectin in Developing Human and Calf Bone Using Monoclonal
Antibodies. Calciﬁed Tissue International 324:155–161.
[10] Bitar M, Brown Ra, Salih V, Kidane AG, Knowles JC, Nazhat SN. 2008. Eﬀect of
cell density on osteoblastic diﬀerentiation and matrix degradation of biomimetic dense
collagen scaﬀolds. Biomacromolecules 9:129–35. doi:10.1021/bm701112w.
[11] Bleibler F, Konnopka A, Benzinger P, Rapp K, König HH. 2013. The health burden and costs of incident fractures attributable to osteoporosis from 2010 to 2050 in
Germany a demographic simulation model. Osteoporosis International :835–847doi:
10.1007/s00198-012-2020-z.
[12] Bohner M. 2000. Calcium orthophosphates in medicine: From ceramics to calcium
phosphate cements. Injury 31:37–47. doi:10.1016/S0020-1383(00)80022-4.
[13] Boukhechba F, Balaguer T, Michiels JF, Ackermann K, Quincey D, Bouler JM, Pyerin
W, Carle GF, Rochet N. 2009. Human primary osteocyte diﬀerentiation in a 3D culture
system. Journal of bone and mineral research : the oﬃcial journal of the American
Society for Bone and Mineral Research 24:1927–35. doi:10.1359/jbmr.090517.
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APPENDICES
A

HYDROXYAPATITE SYNTHESIS PROTOCOL

Solutions:
‹ (NH4 )2 HPO4 , 10mM, MW: 132.06 g/mol (Ammonium Phosphate)
– 0.528 g in 400 mL MilliQ H2 O
‹ Ca(NO3 )2 , 10 mM, MW: 236.15 g/mol (Calcium Nitrate tetra hydrate)
– 1.4632 g in 620 mL MilliQ H2 O
– Prepare solution within a 1 L round-bottom glass beaker.
– Keep beaker in an ice bath during synthesis, with ice/water coverage reaching to
near the base of the neck of the beaker.
‹ NH4 OH, 0.1 M (Ammonium Hydroxide) make in chemical hood, as this solution
releases strong fumes.
– From 28-30% bottle: Make 1 L of 0.1 M: 13.5 mL into 986.5 mL dH2 O.
‹ Note: this procedure must be done using the full volumes of solution. There will be a
signiﬁcant diﬀerence in the product if half-quantities are used.

Synthesis Protocol
1. Add 372 mL (NH4 )2 HPO4 drop-wise into the Ca(NO3 )2 , while stirring at 600 rpm
with a stirring pill approximately 35 mm long and 15 mm in diameter.
(a) Administer the (NH4 )2 HPO4 using 2 to 3 25 mL syringes ﬁtted with tubes leading
into the beaker.
(b) The pumping rate should be set to approximately 1.4 mL/minute.
(c) Maintain the pH at 9-9.5 using diluted Ammonium Phosphate (1-2% solution).
(d) After 50-75 mL have been added, the solution should begin to appear cloudy.
2. After 372 mL (NH4 )2 HPO4 has been added, leave the beaker stirring for 1 hour. Add
more ice if needed (unlikely).
3. Remove the beaker from the ice bath, and leave stirring for 12 hours.
4. Transfer solution to 50 mL centrifuge tubes (6-12 at a time), and centrifuge at 1,200
rpm for 5 minutes.
5. Decant all but 5-10 mL supernatant into a waste container, and add additional solution
from the beaker. Repeat steps 4 and 5 until all solution has been emptied from the
beaker.
6. Once beaker is empty, add 100-200 mL 0.1 M NH4 OH to the beaker, swirl to rinse,
and transfer to the 50 mL tubes.
7. Add additional 0.1 M NH4 OH to each 50 mL tube, up to approximately the 35 or
40 mL line, and vortex until the HA is homogenized into a suspension. Centrifuge at
1,200 rpm for 5 minutes, and decant.
8. Repeat Step 7 until the contents of the tubes have been rinsed 4-5 times with the
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NH4 OH.
(a) If beginning with 12 tubes, in the third-to-last rinse, combine the contents of the
tubes into 8 of the tubes.
i. To combine, suspend the contents of one tube in 20 mL NH4 OH, transfer to
a second decanted tube.
ii. Add another 10 mL NH4 OH to the ﬁrst tube, vortex to rinse, and add to the
second decanted tube.
iii. Fill to the 35-40 mL line with additional NH4 OH, and vortex until homogenized.
iv. During the next rinse, repeat this to combine the 8 tubes into 4 tubes.
v. During the ﬁnal rinse, repeat to combine the 4 tubes into 2 tubes.
(b) If beginning with 8 tubes, combine in the second-to-last and ﬁnal rinses, as above.
(c) If beginning with 6 tubes, combine to 4 tubes, and then into 2 tubes, as above.
(d) During these rinses, make sure that the lyophilizer is started so that it is ready
for the HA after all rinsing steps are complete.
9. Add Acetone to the remaining two 50 mL tubes up to the 25 mL line, vortex until the
HA is homogenized into suspension, and centrifuge at 1,200 rpm for 5 minutes, and
decant. Repeat.
10. Add MilliQ to the tubes, up to the 35 or 40 mL line, vortex into a homogenous
suspension, centrifuge at 1,200 rpm for 5 minutes, and decant. Repeat.
11. Suspend the contents of one of the tubes in MillliQ water, transfer to the other tube.
Add MilliQ into the ﬁrst tube, vortex to rinse, and transfer to the second tube. Centrifuge and decant.
12. Add a small quantity of MilliQ (no more than 10 mL) to the tube, suspend and
immediately place the tube into liquid nitrogen for at least 1 minute.
13. Place a piece of paraﬁlm over the top of the tube, and secure it using a hair tie. Punch
several small holes into the paraﬁlm (e.g., with a needle).
(a) Depending on how long this step takes, you may need to brieﬂy dip the lower half
of the 50 mL tube in the liquid nitrogen again to prevent premature thawing.
14. Place the tube into the lyophilizer and run for at least 2-3 days. When the HA is dry,
it should have a ﬂuﬀy appearance comparable to cotton candy.
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B

PROTOCOL FOR THE PREPARATION AND
MAINTENANCE OF 3D CELL CULTURES

Prepare beforehand:
‹ PEEK dish (top and bottom halves), 4 screws, nylon membrane, and silicon gasket,
all autoclaved and assembled with ﬂame-sterilized tools. Dish should be residing in a
10 cm petri dish.
‹ 2x autoclaved 2 mL tubes per cellularized culture
‹ 1x autoclaved 2 mL tube per non-cellularized culture
‹ 1x autoclaved 1.7 mL conical tube per cellularized culture

3D Culture Preparation
‹ If using DMP1-Cre x mT/mG cells:
– Image culture dish in at least 3 locations via epiﬂuorescent microscopy.
– Images should be taken of each location for red and green ﬂuorescence.
– Verify that green cells make up a small minority of visible cells in each image
(estimated < 5%)
‹ Rinse 10 cm petri dishes with 3 mL DPBS, twice.
‹ Add 3 mL 0.05% Trypsin-EDTA or TrypLE to the dish, and incubate for 5-6 minutes.
‹ Tap the bottom of the dish, and observe via an inverted microscope to verify lifting of
cells.
‹ Transfer solution in dishes to 15 mL tube, rinse dishes with 2 mL DBPS to lift cells,
and transfer rinse to tube. Add 5 mL warm Alpha MEM to dish, and transfer to the
tube. Centrifuge at 1,200 rpm for 5 minutes.
‹ Aspirate supernatant, resuspend pellet in a small quantity of Alpha MEM, and count
the cells. Aliquot suspension into 1.7 mL tubes at quantities of 0.825 x 106 cells per
culture.
‹ Microcentrifuge 1.7 mL tubes at 1,200 rpm for 3 minutes. Rotate tubes 180, and
microcentrifuge again at 1,200 rpm, for 2 minutes. If suspended concentration is too
low for 1.7 mL tube to contain 1-2 cultures worth of cells, add up to 1.5 mL suspension
at a time, microcentrifuge 3 minutes, aspirate supernatant, and repeat, until suﬃcient
cells are present in the tube.
‹ Following microcentrifugation, aspirate supernatant such that the volume of Alpha
MEM present in the 1.7 mL tube is the volume of the pellet.
‹ Mix PSC solutions at volumes of 1.2x the ﬁnal culture volume if preparing nonmineralized cultures, and 1.3x the ﬁnal culture volume if preparing mineralized cultures.
‹ Transfer the appropriate volume of PSC mixture to the 1.7 mL tube with the pelleted
cells (1.1 mL PSC per 1 mL ﬁnal culture volume for cultures without added HA, 0.6
mL PSC per 1 mL ﬁnal culture volume for cultures with added HA). Homogenize the
pellet via pipetting until no pieces of the pellet are visible.
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‹ For cultures with added hydroxyapatite, transfer 0.6 mL PSC per 1 mL ﬁnal culture
volume to the corresponding tube of HA, and pipet until homogenized (no visible
clumps of HA remaining). Transfer the HA suspension to the 1.7 mL tube containing
the corresponding cell suspension, and pipette the suspensions together.
‹ Transfer 0.51 mL (rather than 0.5 mL, to accommodate volume loss in transfer) of the
mixture to a slot in the PEEK dish, and deposit into the slot, making sure that the
mixture settles to the bottom of the slot, is evenly-distributed across the slot, and does
not contain any large bubbles. Incubate the dish for 10-12 minutes for the collagen to
polymerize.
‹ After incubation, add approximately 1 mL complete Alpha MEM to the newly-occupied
slots to keep cultures from drying and prevent cell starvation.
‹ Add additional cultures to the dish as needed. To prevent pre-polymerization settling
of the cultures or premature polymerization of the collagen, PSC mixtures should be
prepared no more than 2 at a time, along with the corresponding cell or cell+HA
mixtures.
‹ After all necessary cultures have been added to PEEK dish and polymerized, ﬁll the
petri dish with approximately 35 mL complete Alpha MEM (top of the culture medium
should reach just below the external interface of the top and bottom halves of the PEEK
dish). Using a 1 mL pipette, lift and drop the slotted sides of the PEEK dish to remove
bubbles beneath it. Add more medium as needed.

Procedure for Culture Maintenance
‹ Aspirate culture medium to the top of the slots at the bottom of the PEEK dish. Tilt
the dish toward one of the slotted sides, and aspirate most of the medium from the
top side of the culture slots, being careful not to dislodge the cultures.
‹ Add new culture medium onto the cultures, and add new medium to the petri dish
until the ﬂuid level reaches just below the external interface of the top and bottom
halves of the PEEK dish. Using a 1 mL pipette, lift and drop the slotted sides of the
PEEK dish to remove bubbles beneath it. Add more medium as needed.
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C

3D CULTURE HARVESTING PROTOCOL

‹ Processing of PEEK dish from the culture environment.

1. Vacuum culture medium out of petri dish and most of the wells in the PEEK
dish, without disrupting the 3D culture constructs.
2. Rinse the petri dish with approximately 25 mL DPBS, and add 1.5 mL DPBS to
each well in the PEEK dish.
3. Gently swirl the petri dish around, and then vacuum out the DPBS.
4. Repeat rinsing and vacuuming.
‹ Preparation of mechanical testing samples.
1. Prepare a 2 mL tube with approximately 1 mL of MilliQ water, for each of the
3D cultures being harvested, each labeled to identify the sample.

2. Unscrew the top half of the PEEK dish.
3. Carefully remove the top half of the dish, and set aside. The 3D cultures should
all remain on the nylon membrane. If any cultures come oﬀ of the membrane
with the top half of the dish, gently push them back onto the membrane using
round-tipped foreceps, or a similar impliment that will not damage the cultures.
4. Using foreceps, pick up one edge of the nylon membrane, lift up from the bottom
half of the dish, and pull away the bottom half from under the membrane. The
silicon gasket should ramain on the bottom half of the dish. Set the bottom half
of the dish aside.
5. Set a caliper to 4 mm, and lock it into position. Place the tips of the large jaws
of the caliper onto the nylon membrane, just adjacent to one end of the culture
the sample is going to be taken from.
6. Use a scalpel to make cuts perpendicular to the culture, sliding the blade along
the inside edges of the large jaws of the caliper to ensure the width of the section
being cut.
7. Move the caliper over, such that the tip of a large jaw of the caliper sits in the
hole in the nylon membrane where the tip of the other jaw was previously.
8. Make another cut, using the inside edges of the jaws as a reference.
9. Place the cut-out sections into the appropriate 2 mL tube.
10. Use for mechanical testing within 6 hours to avoid signiﬁcant alterations in the
matrix properties due to changes in cellular conditions.
11. Rinse the halves of the PEEK dish with DI water, in order to remove residual
medium, and place the nylon membrane back onto the bottom half. Ensure that
the cultures are in their original position on the membrane, and place the top
half of the PEEK dish back onto the bottom half. It is not necessary to place the
screws back in.
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‹ PFA Fixing
1. Place the PEEK dish with the 3D cultures into a large beaker such that the dish
can sit ﬂat on the bottom, and place the beaker into a fume hood.

2. Gently pour in 140 mL warm or room-temperature 4% PFA, and ensure that the
wells are all ﬁlled with the PFA.
3. Leave the cultures to sit for 75 minutes.
4. While waiting, begin preparing the parallel razor blades for cutting confocal imaging sections (see below) and EtOH tubes for uCT samples.
5. After 75 minutes, transfer the PEEK dish to a beaker with ≥ 200 mL MilliQ
water, and leave sitting for 10 minutes.
6. Transfer the PEEK dish to another beaker with ≥ 200 mL MilliQ water, and
leave sitting for another 10 minutes.
7. If desired, repeat step 6.
8. Remove the dish from the beaker, and proceed with collecting confocal imaging
samples and µCT samples.
‹ Confocal Imaging Samples
1. Prepare the glass slide
(a) Using a scalpel blade, cut out a rectangular piece of 0.54 mm-thick silicon.

(b) Cut out a rectangular space within the silicon measuring approximately 35
mm2 per cellularized culture sample being processed.
(c) Ensure that the prepared silicon gasket is clean from dust and debris, then
place onto a 25 x 50 mm glass coverslip.
2. Prepare the parallel blades
(a) Split a double-edged razor blade into halves.
(b) Place layers of double-sided tape onto one of the halves, at least 5 mm from
the edge of the blade, until a caliper measurement of the blade with the
double-sided tape reads 0.6±0.05 mm.
(c) Press the other half of the blade onto the tape, such that the blade edges are
aligned.
(d) Place a piece of tape around the parallel blades, at least 5 mm from the blade
edges.
3. Place the nylon membrane with the 3D culture samples onto the top half of the
petri dish.
4. Holding the blades parallel with the lid of the petri dish, press against the 3D
culture sample, sliding the blades along the edges while doing so, until pressing
against the nylon membrane. Slide the blades back to ensure completion of the
cuts through the sample.
5. Lift the blade. If the section remains on the membrane, next to the rest of the 3D
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culture sample, transfer the cut section with foreceps to the glass coverslip within
a cut-out space. If the section stayed between the razor blades, use a 22-gauge
needle to remove it, and place it onto the glass coverslip.
6. Repeat for at least 2 other sections for that sample.
7. When sections for a sample have all been placed into the appropraite space on the
coverslip, add a few drops of mounting medium to cover the sections and protect
them from drying.
8. Repeat steps 4-7 for each cellularized sample, using the remaining portions of
within the rectangular piece of silicon to divide groups of culture sections on the
slide.
9. After all sections have been placed onto the slide and been covered by mounting
medium, remove any bubbles in the medium, and place another 25 x 50 mm
coverslip over sections, and press until the top coverslip is in contact with the
silicon gasket.
10. Keep slide in the dark, at room temperature, for at least 24 hours.
‹ Confocal Imaging Samples
1. Transfer remainder of ﬁxed culture samples to appropriately-labeled 70% EtOH
tubes, and store in a refrigerator until later use.

